This study is a registry for women with early-stage breast cancer who are receiving Intraoperative Radiation Therapy (IORT) during breast-conserving surgery. IORT involves a single dose of radiation (50kV X-rays to a dose of 20 Gy) given during surgery. The purpose is to track the long-term effects of this treatment, including any complications, if the cancer comes back (recurrence), and how long patients live without the disease or overall. You might be able to join if you have early-stage breast cancer (Tis, T1, or T2, N0, M0), the cancer is in one spot (unifocal), and your medical team recommends breast-conserving surgery. The study aims to see how effective and safe IORT is over time, with success measured by whether the disease recurs after 5 years. The current recruitment status is unclear.

Study design

This is an observational study, meaning researchers will collect information about your treatment and health outcomes. It plans to include 1000 participants.

What's involved

Not specified in the trial record.

Compensation

Not stated in the trial record.

Follow-up

Your health will be tracked to see if the disease recurs, with measurements taken at 5 years.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.